Techno Trends
Biogen to acquire British biopharmaceutical firm Convergence
US-based Biogen Idec is set to acquire British clinical-stage biopharmaceutical company, Convergence Pharmaceuticals. As part of the deal, Convergence shareholders will...
Industry Reports
Ireland’s Shire to acquire NPS Pharmaceuticals for $5.2bn
Irish drugmaker Shire has signed a merger agreement to acquire US-based NPS Pharmaceuticals for $5.2bn. As part of the deal, Shire...
News
Pharma ‘shocked’ as drugs cut from Cancer Drugs Fund
Pharma companies have attacked the decision to remove some drugs from England's Cancer Drugs Fund (CDF), in a move aimed at de-listing drugs which...
Clinical Trials
Enox Biopharma, LTD. Announces First Enrollments of A Phase 1a/lb Clinical Trial
Enox Biopharma, Ltd., a leader in nitric oxide delivery technology for the prevention of hospital acquired infections announced today the enrollment of the first...
Clinical Trials
Otsuka and GW Pharmaceutical’s multiple sclerosis drug Sativex has failed to meet the primary endpoint in its first Phase III trials in cancer pain.
Sativex (nabiximols) is derived from cannabis and usually used to treat the symptoms of multiple sclerosis (MS). This trial was testing the drug for...
Press Releases
Director General of EFPIA: “Pan-European HTA necessary”
Richard Bergström, Director General, EFPIA argued passionately in favour of the homogenisation of European HTA bodies and regulation, during a recent interview with Paul...
Press Releases
Eli Lilly acquires Novartis Animal Health for $5.4bn
US-based Eli Lilly and Company has completed the acquisition of Novartis Animal Health for $5.4bn. Lilly noted the acquisition was funded...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read